Drug Shortage Report for PROTAMINE SULFATE INJECTION, USP

Last updated on 2021-04-13 History
Report ID 133511
Drug Identification Number 02139537
Brand name PROTAMINE SULFATE INJECTION, USP
Common or Proper name Sulfate de protamine injectable, USP 10 mg/mL, fiole DU, 25 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) PROTAMINE SULFATE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 25 mL
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-02-02
Actual start date 2021-02-02
Estimated end date 2021-04-12
Actual end date 2021-04-12
Shortage status Resolved
Updated date 2021-04-13
Company comments Fresenius Kabi Canada Ltd. is pleased to advise that both sizes of our Protamine Sulfate Injection, USP have been removed from allocation as of Monday, April 12, 2021. The products will be available to all customers through all distribution channels without any volume restrictions.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-04-13 English Compare
v6 2021-04-09 French Compare
v5 2021-04-09 English Compare
v4 2021-04-09 French Compare
v3 2021-04-09 English Compare
v2 2021-02-05 French Compare
v1 2021-02-05 English Compare

Showing 1 to 7 of 7